Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain Amyloidosis
Clinical trial NCT01318902 · COMPLETED
Trial details
- NCT number
- NCT01318902
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-27
- Primary completion
- 2018-11-13
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.